Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Nasopharyngeal Carcinoma 7Small Cell Lung Carcinoma 4Carcinoma, Renal Cell 4Triple Negative Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Neoplasms 3Esophageal Squamous Cell Carcinoma 3Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Advanced Solid Tumor 3Stomach Neoplasms 2Neoplasm Metastasis 2Head and Neck Neoplasms 2Breast Neoplasms 2Advanced Breast Cancer 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Turcot syndrome 1Solid Tumor 1Skin Neoplasms 1Sarcoma 1Recurrence 1Papillomavirus Infections 1Pancreatic Neoplasms 1Pancreatic Cancer Metastatic 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1NSCLC 1Muscle Invasive Bladder Cancer (MIBC) 1

Interventions

pembrolizumab 66Cisplatin 40Carboplatin 25Cetuximab 23Magnetic Resonance Spectroscopy 19Paclitaxel 18Nivolumab 17Specimen Handling 16Radiotherapy, Intensity-Modulated 16Radiotherapy 14Docetaxel 13Platinum 121,2-diaminocyclohexaneplatinum II citrate 11Fluorouracil 9Taxes 8Biopsy 8atezolizumab 6cemiplimab 5Surgical Procedures, Operative 5Radiation 5Ipilimumab 5(225)Ac-DOTA-c(RGDyK) 5dostarlimab 4Standard of Care 4Immunoglobulin G 4Immune Checkpoint Inhibitors 4Cyclophosphamide 4Bevacizumab 4Albumin-Bound Paclitaxel 4toripalimab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × toripalimab × 90 days × Clear all
NCT06378177 2026-05-19

A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC)

Lyvgen Biopharma Holdings Limited

Phase 2 Active not recruiting
64 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT07423078 2026-04-13

WOLF

University of Pittsburgh

Phase 2 Recruiting
87 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

NCT05635643 2026-03-19

Study of CHS-114 in Participants With Advanced Solid Tumors

Coherus Oncology, Inc.

Phase 1 Recruiting
87 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡